Intravitreal Administration of the Anti-Tumor Necrosis Factor Agent Infliximab for Neovascular Age-related Macular Degeneration

Ranibizumab for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al. · New England Journal of Medicine · 2006 · 5.8K citations · Full text

Pegaptanib for Neovascular Age-Related Macular Degeneration

Evangelos S. Gragoudas, Anthony P. Adamis, Emmett T. Cunningham et al. · New England Journal of Medicine · 2004 · 2.3K citations · Full text

The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes.

Hideyasu Oh, Hitoshi Takagi, Chieko Takagi et al. · PubMed · 1999 · 399 citations

Mechanisms for cytotoxic effects of anti–tumor necrosis factor agents on transmembrane tumor necrosis factor α–expressing cells: Comparison among infliximab, etanercept, and adalimumab

Hiroki Mitoma, Takahiko Horiuchi, Hiroshi Tsukamoto et al. · Arthritis & Rheumatism · 2008 · 343 citations

Apoptosis, Immunology, Immune Regulation +26

A Prospective Trial of Infliximab Therapy for Refractory Uveitis

Eric B. Suhler · Archives of Ophthalmology · 2005 · 300 citations